Table 2.

– HIFU treatment technical details (n = 45)

Ideal according to consensus criteria, n (%)	26 (57.8)
Prostate volume, median (IQR)	35 (27–46)
Location of treatment (combined treatment fields for n = 5 with 2 HIFU treatments)
Hemi-gland unilateral
Hemi-gland with extension across midline or into SV	16
Hemi-gland anterior	7
Hemi-gland posterior	1
Quadrant (e.g. unilateral posterior)	1
Focal ablation (eg posterior right basal segment)	13
Subtotal (extended hemi-ablation, sparing lateral aspect of contralateral side)	6
	1
Number of HIFU treatments
1	37
2	8
Known ‘insignificant’ cancer left untreated at HIFU
Yes	21 (47.7)
No	23 (52.3)
Type of biopsy pre-HIFU:
TTMB TP 5 mm Mapping + MRI-Targeted (if targets)	24 (53.3)
12–20 core TRUS + MR-targeted (if targets)	17 (37.8)
Targeted alone	3 (6.7)
Not documented	1 (2.2)